This was the stock's third consecutive day of losses.

This was the stock's second consecutive day of losses.

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Between February 3, 2025, and February 7, 2025, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved ...

After hours: February 7 at 7:27:43 PM EST Loading Chart for INO ...

Conduent Incorporated , a global technology-led business solutions and services company, today announced that the Oklahoma State Department of Health (OSDH) has selected the company's Maven® Disease ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

As the healthcare market hit lows during the coronavirus scare, these blue-chip companies brought hope for a vaccine from Gilead Sciences (NASDAQ: GILD), Inovio Pharmaceuticals (NASDAQ ...

Feb. 6, 2025 — A new, comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite that causes malaria in humans, has been generated. The ...